[1]
B. Srinivasa Rao, B Sai Kumar, and A. Uma, “Barotrauma, timing of Tocilizumab and Invasive ventilationas predictors of mortality with inflammatory markers and comorbidities in critically ill COVID-19 patients: A retrospective study”, Int. J. Heal. Clin. Res., vol. 5, no. 2, pp. 456–458, Jan. 2022.